Harvard
Boston, Massachusetts, United States
Disclosure(s): Generate Biomedicines (Ongoing) (Products/Services: Consultant, Intellectual Property including patent beneficiary and royalties, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Friday, April 28, 2023
3:45 PM – 5:15 PM ET